phloroglucinol has been researched along with gemcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammerpohl, O; Bohm, B; Brockschmidt, C; Eismann, T; Giamas, G; Henne-Bruns, D; Hillenbrand, A; Hirner, H; Huber, N; Kalthoff, H; Knippschild, U; Leithäuser, F; Radunsky, B; Trauzold, A | 1 |
| Hilger, RA; Hoheisel, JD; Holtrup, F; Werner, J; Wolf, RJ | 1 |
2 other study(ies) available for phloroglucinol and gemcitabine
| Article | Year |
|---|---|
Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; Casein Kinase 1 epsilon; Casein Kinase Idelta; Cell Proliferation; Deoxycytidine; Drug Evaluation, Preclinical; fas Receptor; Gemcitabine; Humans; Indoles; Lymphatic Metastasis; Mice; Mice, SCID; Neoplasm Transplantation; Pancreatic Neoplasms; Phloroglucinol; Transplantation, Heterologous; Tumor Cells, Cultured | 2008 |
In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts.
Topics: Animals; Antineoplastic Agents; Benzophenones; Biological Availability; Biotransformation; Carcinoma; Caspase 3; Cytochrome P-450 CYP3A; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Gene Expression; Half-Life; Hepatocytes; Humans; Injections, Subcutaneous; Ki-67 Antigen; Mice; Mice, Nude; Pancreatic Neoplasms; Phloroglucinol; Primary Cell Culture; Terpenes; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2013 |